DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹455 Cr | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹455 Cr |
| Mar2025 | ₹498 Cr |
| Mar2024 | ₹572 Cr |
| Mar2023 | ₹523 Cr |
| Mar2022 | ₹407 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹455 Cr | -8.63 | |
| Mar2025 | ₹498 Cr | -12.94 | |
| Mar2024 | ₹572 Cr | 9.37 | |
| Mar2023 | ₹523 Cr | 28.52 | |
| Mar2022 | ₹407 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹294,997.1 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹108,424.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.7% |
27.2% |
71.1% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses